Lowering serum lipids

The present invention provides methods for lowering serum lipids in a patient by administering a GLP-1 agonist. The invention is useful for treating diseases that may be alleviated by lowering serum lipid levels, including, e.g., cardiovascular disease and diabetes.

Saved in:
Bibliographic Details
Main Author KNUDSEN LISELOTTE BJERRE
Format Patent
LanguageEnglish
Published 27.02.2003
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides methods for lowering serum lipids in a patient by administering a GLP-1 agonist. The invention is useful for treating diseases that may be alleviated by lowering serum lipid levels, including, e.g., cardiovascular disease and diabetes.
Bibliography:Application Number: US20010800541